If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
| pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
|
378
|
371
|
559
|
128
|
154
|
1558
|
Gene and significance breakdown #
Total genes and gene combinations: 52
| Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
|
GCK
|
215
|
190
|
87
|
8
|
4
|
484
|
|
HNF1A
|
109
|
114
|
155
|
14
|
19
|
404
|
|
HNF4A
|
48
|
52
|
99
|
12
|
9
|
215
|
|
ALMS1
|
0 |
0 |
4
|
35
|
26
|
65
|
|
WFS1
|
0 |
0 |
30
|
7
|
14
|
51
|
|
GLIS3
|
0 |
0 |
18
|
5
|
6
|
29
|
|
PPP1R3A
|
0 |
0 |
11
|
5
|
9
|
25
|
|
C12orf43, HNF1A
|
2
|
6
|
12
|
1
|
3
|
24
|
|
ABCC8
|
0 |
3
|
12
|
1
|
2
|
18
|
|
AGPAT2
|
0 |
0 |
9
|
1
|
3
|
13
|
|
RFX6
|
0 |
1
|
4
|
7
|
1
|
13
|
|
LEPR
|
0 |
0 |
10
|
2
|
0 |
12
|
|
BLK
|
0 |
0 |
6
|
1
|
4
|
11
|
|
INSR
|
0 |
0 |
5
|
4
|
2
|
11
|
|
PDX1
|
0 |
0 |
6
|
0 |
5
|
11
|
|
PLIN1
|
0 |
0 |
2
|
3
|
5
|
10
|
|
ZFP57
|
0 |
0 |
5
|
0 |
5
|
10
|
|
BSCL2, HNRNPUL2-BSCL2
|
1
|
0 |
6
|
1
|
1
|
9
|
|
EIF2AK3
|
0 |
0 |
5
|
1
|
3
|
9
|
|
HADH
|
0 |
0 |
7
|
0 |
2
|
9
|
|
MC4R
|
1
|
0 |
5
|
1
|
2
|
9
|
|
GATA6
|
0 |
0 |
4
|
2
|
2
|
8
|
|
HNF1B
|
0 |
0 |
6
|
1
|
1
|
8
|
|
KLF11
|
0 |
0 |
2
|
2
|
4
|
8
|
|
PAX4
|
0 |
0 |
3
|
2
|
3
|
8
|
|
CEL
|
0 |
0 |
2
|
1
|
4
|
7
|
|
KCNJ11
|
0 |
1
|
4
|
0 |
2
|
7
|
|
PTF1A
|
0 |
0 |
7
|
0 |
0 |
7
|
|
SIM1
|
0 |
0 |
6
|
1
|
0 |
7
|
|
CAVIN1
|
0 |
0 |
5
|
1
|
0 |
6
|
|
LMNA
|
1
|
1
|
2
|
1
|
1
|
6
|
|
SLC2A2
|
0 |
0 |
3
|
0 |
3
|
6
|
|
ALMS1, LOC126806252
|
0 |
0 |
2
|
3
|
0 |
5
|
|
SLC19A2
|
0 |
0 |
2
|
1
|
1
|
4
|
|
intergenic
|
0 |
2
|
1
|
0 |
0 |
3
|
|
FOXP3
|
0 |
0 |
2
|
0 |
1
|
3
|
|
LOC127407129, RFX6
|
0 |
0 |
1
|
1
|
1
|
3
|
|
PPARG
|
0 |
0 |
3
|
0 |
0 |
3
|
|
APPL1
|
0 |
0 |
2
|
0 |
0 |
2
|
|
CAV1
|
0 |
0 |
2
|
0 |
0 |
2
|
|
INS, INS-IGF2
|
1
|
1
|
0 |
0 |
0 |
2
|
|
LOC125146351, PLIN1
|
0 |
0 |
0 |
1
|
1
|
2
|
|
NEUROD1
|
0 |
0 |
1
|
0 |
1
|
2
|
|
BLK, LOC126860303
|
0 |
0 |
1
|
0 |
0 |
1
|
|
BSCL2, GNG3, HNRNPUL2-BSCL2
|
0 |
0 |
0 |
0 |
1
|
1
|
|
GLUD1
|
0 |
0 |
1
|
0 |
0 |
1
|
|
GLUD1, LOC130004254
|
0 |
0 |
0 |
0 |
1
|
1
|
|
GLUD1, LOC130004255, SHLD2
|
0 |
0 |
0 |
1
|
0 |
1
|
|
LEP
|
0 |
0 |
0 |
0 |
1
|
1
|
|
LEPR, LOC122094844
|
0 |
0 |
0 |
0 |
1
|
1
|
|
LOC126859771, RFX6
|
0 |
0 |
0 |
1
|
0 |
1
|
|
LOC129931894, SLC19A2
|
0 |
0 |
1
|
0 |
0 |
1
|
Submitter and significance breakdown #
| Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
|
ClinGen Monogenic Diabetes Variant Curation Expert Panel
|
344
|
341
|
332
|
33
|
33
|
1080
|
|
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
|
1
|
0 |
213
|
95
|
121
|
430
|
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
50
|
24
|
0 |
0 |
0 |
74
|
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
|
0 |
6
|
13
|
0 |
0 |
19
|
|
Translational Genomics Laboratory, University of Maryland School of Medicine
|
7
|
7
|
0 |
0 |
0 |
14
|
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
0 |
1
|
7
|
0 |
2
|
10
|
|
Biomedical Genomics and Oncogenetics Laboratory, Institut Pasteur de Tunis, University Tunis El Manar
|
0 |
1
|
0 |
1
|
0 |
2
|
|
Molecular Genetics, Royal Melbourne Hospital
|
1
|
1
|
0 |
0 |
0 |
2
|
|
Smedley Team, Phenogenomics Group, Queen Mary University of London
|
0 |
2
|
0 |
0 |
0 |
2
|
|
Genetics and Molecular Pathology, SA Pathology
|
0 |
1
|
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. The submitted information has not been verified.
If you have questions about the information contained on this
website, please see a health care professional.